Posts by Raymond J. March
Raymond J. March is a Research Fellow at the Independent Institute and Assistant Professor of Economics at San José State University. His research examines the public and private provision and governance of healthcare in the United States, particularly in pharmaceutical markets.
FDA Approves Record Number of Generic Drugs in 2018


With U.S. drug prices among the highest in the world, generics provide significant financial relief for millions using prescription drugs.

Teen Vaping Is Bad, but the Alternative Is Worse


The FDA’s efforts to reduce teen vaping rates will likely result in worse health outcomes by prompting teens to switch to smoking cigarettes.

Can the FDA Prevent Teens from Vaping?


Epidemics are causes for concern, but before we declare regulation to be the cure, we should question who administers the treatment.

Deregulation Is the Only Cure for High Drug Prices


The FDA’s influence in the prescription drug market remains the largest obstacle to deregulation.

FDA Vaping Regulations Will Do More Harm than Good


Stringent regulations on the e-cigarette market to come.

To Help the Terminally Ill, the FDA Must Deregulate


Right-to-try will never reach its potential without deregulation.

When Healthy Policy Neglects Economic Principles, Patients Suffer


Recent events indicate an urgent need for researchers and policymakers to relearn the basics.

FDA Still Hooked on Meddling in Nicotine Markets


FDA launches anti-vaping campaign.

FDA Struggles to Develop “Sugar Added” Labels for Honey and Maple Syrup


An example of sweet intentions bearing stale outcomes.

Let Competition, Not the FDA, Resolve the EpiPen Shortage


The only reliable remedy to mitigate shortages of any product is to allow competition in the market.

  • Catalyst
  • MyGovCost.org
  • FDAReview.org
  • OnPower.org
  • elindependent.org